Founders Financial Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,450
Closed -$216K 259
2021
Q4
$216K Buy
+2,450
New +$216K 0.04% 243